日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

KIF2A-mediated microtubule-dependent nuclear envelope invagination drives nonhomologous end joining.

KIF2A介导的微管依赖性核膜内陷驱动非同源末端连接。

期刊:Nucleic Acids Research
影响因子:13.1
doi:10.1093/nar/gkag004
Ma Yujie, Zhang Tianyi, Zhou Xiao Albert, Xu Zhanzhan, Zhou Jiadong, Aili Abudureyimujiang, Li Pei, Nie Chen, Xiong Yundong, Li Xiaoman, Cao Baoshan, Li Shiwei, Wang Jiadong
KIF2A
发表日期：2026
文献求助 收藏

Consensus on Human Epidermal Growth Factor Receptor 2 Overexpression Testing in Pan‐Tumor

关于泛肿瘤中人表皮生长因子受体2过表达检测的共识

期刊:Journal of Molecular Biology
影响因子:4.5
doi:10.1016/j.jmb.2025.169044
Nussinov, Ruth; Wang, Zhe; Chen, Lin; Rao, Wei; Cao, Baoshan; Cai, Muyan; Fan, Xiangshan; Ji, Yuan; Li, Yuan; Song, Yan; Sun, Yan; Sun, Yu; Wu, Chunyan; Xia, Qingxin; Xi, Yanfeng; Xue, Liyan; Yin, Rutie; Liang, Han; Ying, Jianming
信号转导
Human
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Harnessing Tumor Organoids to Revolutionize Immunotherapy Research

利用肿瘤类器官革新免疫疗法研究

期刊:Cancer Medicine
影响因子:3.1
doi:10.1002/cam4.71776
Wang, Zhen; Yin, Peipei; Cui, Shizhan; Liu, Hui; Li, Dan; Yu, Yang; Cao, Baoshan; Liu, Xiaojuan
3D/类器官
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2026
文献求助 收藏

Clinical efficacy and cardiac toxicity associated with first-line dabrafenib plus trametinib in advanced BRAF V600_K601delinsE-mutated lung adenocarcinoma: a case report and literature review

一线达拉非尼联合曲美替尼治疗BRAF V600_K601delinsE突变型晚期肺腺癌的临床疗效及心脏毒性：病例报告及文献综述

期刊:Discover Oncology
影响因子:2.9
doi:10.1007/s12672-026-04607-y
Yang, Lu; Liu, Xuanjun; Zhu, Xiang; Cao, Baoshan; Gu, Yangchun; Liu, Wei
BRAF
肿瘤
毒理研究
肿瘤免疫
发表日期：2026
文献求助 收藏

Consensus on Human Epidermal Growth Factor Receptor 2 Overexpression Testing in Pan-Tumor

关于泛肿瘤中人表皮生长因子受体2过表达检测的共识

期刊:Cancer Innovation
影响因子:2
doi:10.1002/cai2.70060
Wang, Zhe; Chen, Lin; Rao, Wei; Cao, Baoshan; Cai, Muyan; Fan, Xiangshan; Ji, Yuan; Li, Yuan; Song, Yan; Sun, Yan; Sun, Yu; Wu, Chunyan; Xia, Qingxin; Xi, Yanfeng; Xue, Liyan; Yin, Rutie; Liang, Han; Ying, Jianming
Human
发表日期：2026
文献求助 收藏

Targeting KRAS: from metabolic regulation to cancer treatment

靶向KRAS：从代谢调控到癌症治疗

期刊:Molecular Cancer
影响因子:33.9
doi:10.1186/s12943-024-02216-3
Shi, Yanyan; Zheng, Huiling; Wang, Tianzhen; Zhou, Shengpu; Zhao, Shiqing; Li, Mo; Cao, Baoshan
肿瘤
肿瘤免疫
信号转导
代谢
RAS
发表日期：2025
文献求助 收藏

The global progress and quality assessment of research on the association between circulating tumor DNA and clinical prognosis: a systematic review

全球循环肿瘤DNA与临床预后关联研究进展及质量评估：系统评价

期刊:Journal of the National Cancer Center
影响因子:9.4
doi:10.1016/j.jncc.2024.10.002
Zhang, Meng; Chen, Xiaowei; Zhou, Qingxin; Guo, Nana; Cao, Baoshan; Zeng, Hongmei; Chen, Wanqing; Sun, Feng
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Circulating tumor DNA as prognostic markers of non-small cell lung cancer (NSCLC): a systematic review and meta-analysis

循环肿瘤DNA作为非小细胞肺癌（NSCLC）预后标志物：系统评价和荟萃分析

期刊:Translational Lung Cancer Research
影响因子:3.5
doi:10.21037/tlcr-2025-900
Chen, Xiaowei; Zhang, Meng; Zhou, Qingxin; Guo, Nana; Cao, Baoshan; Zeng, Hongmei; Chen, Wanqing; Sun, Feng
肺癌
肿瘤
肿瘤免疫
CLC
细胞生物学
发表日期：2025
文献求助 收藏

Feasibility of systemic therapy in unresectable gastric/gastroesophageal junction cancer with overt bleeding

不可切除的胃/胃食管交界处癌伴明显出血患者行全身治疗的可行性

期刊:Asia-Pacific Journal of Oncology Nursing
影响因子:2.8
doi:10.1016/j.apjon.2025.100750
Yao, Yanhong; Liu, Zhentao; Zhang, Hua; Shi, Xinhua; Huang, Fangfang; Zhang, Yi; Chen, Lu; Shi, Yanyan; Cao, Baoshan
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Recurrent Checkpoint Inhibitor-Related Pneumonitis Refractory to Corticosteroid Treatment: A Case Report and Literature Review

复发性免疫检查点抑制剂相关性肺炎对糖皮质激素治疗无效：病例报告及文献综述

期刊:Clinical Pharmacology-Advances and Applications
影响因子:2.5
doi:10.2147/CPAA.S534323
Yu, Jinyu; Liu, Xuanjun; Ma, Xingjiao; Liang, Li; Liu, Yan'e; Yin, Wencheng; Li, Qian; Cao, Baoshan; Liu, Wei
肺炎
Checkpoint
免疫/内分泌
发表日期：2025
文献求助 收藏